Here we demonstrated that inhibition of wild‐type PBRM1 could also sensitizes RCC to immunotherapy through regulating macrophage‐associated chemokines and increasing M1 macrophage infiltration. This evidence concerns the gene PBRM1 and renal cell carcinoma.